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Abstract
A reaction pairing strategy centered on utilization of a reaction triad (sulfonylation, SNAr addition
and Mitsunobu alkylation) generating skeletally diverse benzofused tricyclic and bicyclic sultams
is reported. Pairing sulfonylation and SNAr reactions yields bridged, tricyclic and bicyclic
benzofused sultams. Application of the Mitsunobu reaction in a sulfonylation–Mitsunobu–SNAr
pairing allows access to benzo-oxathiazocine-1,1-dioxides, while a simple change in the order of
pairing to sulfonylation–SNAr–Mitsunobu affords structurally different, benzofused bridged
tricyclic sultams.
The development of new approaches to access diverse heterocycle collections for high
throughput screening (HTS) is an important aspect in modern drug discovery. Diversity-
oriented synthesis (DOS) has emerged in recent years as an enabling strategy for the
production of diverse collections of heterocycles.1 Key examples of DOS strategies include
functional group pairing and build-couple-pair (BCP).2 We herein report a reaction pairing
strategy utilizing the ability of o-fluorobenzene sulfonamides to undergo nucleophilic
aromatic substitution (SNAr) for the facile generation of benzofused sultam scaffolds.
Sultams (cyclic sulfonamides) represent a class of non-natural chemotypes that have gained
prominence in recent years due to their activity against a wide spectrum of biological
targets.3,4 Long–standing interest in the facile generation of sultam scaffolds has prompted
the exploration of a reaction pairing strategy described herein. o-Halobenzene-sulfonyl
chlorides and their corrsponding sulfonamides have emerged as highly versatile synthons for
the generation of sultam scaffolds.5 While sulfonylation and Mitsunobu alkyaltion are well
precedented for sulfonamides,6 the ability of these synthons to undergo facile nucleophilic
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aromatic substitution (SNAr) is lesser known.2f,5 Collectively, it was therefore envisioned
that pairing of the reaction triad (sulfonylation, SNAr addition and Mitsunobu alkylation) in
varying order alongside the central o-fluorobenzenesulfonyl chloride building blocks could
afford rapid access to both bridged-and fused-tricyclic sultams. This simple approach
obviates the need for construction of elaborate multi-functional scaffolds and would merely
require o-fluorobenzenesulfonyl chlorides, amines and alcohols as building blocks. Simple
changes in the reaction pair sequence (eg. sulfonylation–SNAr vs. sulfonylation–Mitsunobu–
SNAr) or changes in building blocks (1,2-amino alcohol vs 1,3-amino alcohol) allows access
to skeletal and stereochemical diversity (Figure 1).
Investigations commenced with the exploration of pairing (S)-prolinol with 4-bromo-2-
fluorobenzenesulfonyl chloride via a combination of sulfonylation, SNAr and Mitsunobu
methodologies (Scheme 1). Thus, (S)-prolinol was sulfonylated with 4- bromo-2-
fluorobenzenesulfonyl chloride in CH2Cl2/H2O, in the presence of NaHCO3 to provide the
β-hydroxy o-fluorobenzene sulfonamide 1 in 97% yield. Subjection of the sulfonamide to
microwave (mW) irradiation at 150 °C for 30 minutes in DMF in the presence of Cs2CO3
gratifyingly produced the benzofused tricyclic sultam 2 in 88% yield. In contrast, SNAr
addition of (S)-prolinol to n-butyl-derived o-fluorobenzene sulfonamide 3 under mW
irradiation in DMSO at 140 °C for 30 minutes afforded the desired SNAr adduct 4 in 97%
yield. Addition of PPh3 to a stirring solution of the prolinol-derived SNAr adduct in THF
(0.05 M), followed by slow addition of DIAD, was found to proceed quickly (10 minutes) to
furnish the desired tricyclic benzothiadiazepine-1,1-dioxde 5 in 91% yield. Overall, this
approach rapidly furnishes different sultam skeletons implementing a single sulfonyl
chloride in conjunction with an amino alcohol by merely changing the order of reaction
pairing.
With these results in hand, the utilization of this reaction pairing strategy for the generation
of benzofused sultams was explored. Thus, the use of (S)-prolinol alongside propargylamine
derived o-fluorobenzene sulfonamides in the established SNAr–Mitsunobu pairing afforded
the desired tricycylic sultam 6 in good yield (Scheme 2). A simple switch in the amino
alcohol component to (R)-(+)-3-hydroxypyrrolidine gratifyingly afforded the corresponding
bridged, tricyclic benzofused sultams 7 and 8 in good moderate yield. Of notable
importance, is the facile production of the unique bridged tricyclic sultam 7 containing a
bridgehead nitrogen connected to an SO2 moiety. It is proposed that this “bridged sultam”,
like corresponding twisted amides, causes a deviation in the geometry of the sulfonamide
group leading to proposed hybridization and geometry changes at nitrogen, ultimately
affecting physical properties. 7,8 It has been reported that twisted amides (anti-Bredt’
amides) possess a distorted amide bond, which dramatically affect stability and reactivity in
comparison to their standard planar amides while possessing a increased basicity of the
nitrogen.9
Building on these results, utilization of 2-piperidinemethanol in the established reaction
pairing protocol generated the corresponding benzofused tricyclic sultams 9 and 10 in good
yield (Scheme 2). In contrast, use of 3-hydroxypiperidine allowed for the synthesis of the
bridged benzofused sultams 11 and 12 in satisfactory yields (Figure 1), with 11 (see x-ray,
SI) possessing similar bridged sultam’ structural characteristics as 7. Overall, this reaction
pairing sequence allowed for the rapid generation of a skeletally and stereochemically
diverse collection of benzofused sultams by simple variation of the amine component.
Alternatively, it was envisioned that utilization of monoprotected diols, alongside o-
fluorobenzene sulfonamides in a Mitsuonobu alkylation-intramolecular SNAr O-arylation
would allow access to oxygen-containing benzofused sultams 14a–c (Scheme 3).
Accordingly, 3-silyloxy-1-propanol was subjected to Mitsunobu alkylation with n-butyl-
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derived o-fluorobenzene sulfonamide to furnish the 3° sulfonamide 3 in 97% yield. It was
envisioned that deprotection of the TBS group under basic conditions would allow for an
intramolecular SNAr cyclization to take place. Accordingly, a THF solution of 13a was
stirred in the presence of TBAF for 30 minutes under mW irradiation at 150 °C to
gratifyingly afford the desired sultam 14a in 88% yield. Application of the enantiomers (R)-
& (S)-3-((tert-butyldimethylsilyl)oxy)butan-1-ol in the above Mitsunobu–SNAr pairing
sequence was again found to cleanly furnish the corresponding benzothiazocine-1,1-
dioxides 14b and 14c in good yields (Scheme 3). Overall, change in the order of the pairing
of the SNAr reaction with Mitsunobu alkylation to sulfonylation–Mitsunobu–SNAr allows
for face access to skeletally, as well stereochemically, diverse benzofused sultams.
Utilization of a [3+2] Huisgen cycloaddition reaction for the production of triazole-
containing sultams was next explored. Hemming and coworkers have reported the elegent
use of a one pot, tandem alkynylation-[3+2] cycloadditon approach to triazolosultams,10
while a recent report by Yao and co-workers outline the utilization of a Cu catalyzed tandem
[3+2] dipolar cycloadditio–N-arylation approach to these motifs utilizing o-bromo and o-
iodobenzenesulfonamides. 11,12 However, there are no reports of the use of non-metal
catalyzed, SNAr–[3+2] Huisgen cycloaddition for the generation of benzofused sultams.
Thus, a sulfonylation–Mitsunobu protocol using propargyl alcohol and o-fluorobenzene
sulfonamide as the Mitsunobu partners produced the desired propargylated o-fluorobenzene
sulfonamides 16a–d in excellent overall yield (Scheme 4). Azidation of sulfonamides 16a–d
was carried out using NaN3 in DMF at 90 °C in the presence of 18-crown-6 (1 equiv.) for 12
hours to afford the tricyclic triazole-containing sultams 17a–d, which had participated in an
intramolecular [3+2] Huisgen cycloaddition ring closure following intermolecular SNAr
azidation. To the best of our knowledge, this represents the first report of a one-pot tandem
SNAr-intramolecular [3+2] Huisgen cycloadditon for the synthesis of benzofused
sultams.13,14 Overall, the sulfonylation–Mitsunobu–SNAr protocol is augmented by pairing
with an intramolecular [3+2] cycloaddition protocol for the synthesis of triazol-containing
benzofused sultams in 3 steps.
From chemical informatics analysis, utilizing a multifusion similarity (MFS) analysis,15 it is
apparent that sultams 2–12, 14a–c and 17a–d (red) are fairly unique relative to the manifold
of currently available analogs, and that there is a reasonable amount of structural diversity
present.16 Analysis was conducted against all 1198 compounds (blue) currently present in
the NIH Molecular Libraries Probe Production Center Network (MLPCN) that contained the
maximum common substructure (4-bromo-N-propylbenzenesulfonamide) evident within our
own (Figure 2).
In conclusion, we have developed a reaction pairing strategy employing a reaction triad–
sulfonylation, Mitsunobu, SNAr for the rapid synthesis of a diverse collection of benzofused
sultams. Simple changes to the order of the pairing sequence and/or building blocks, allows
for access to skeletal and stereochemical diversity. Overall, this strategy affords a diverse set
of heterocycles in 2–3 steps from commercially available building blocks. These results are
highly amenable for library production to generate collections of skeletally diverse sultams
for HTS screening.
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Reaction pairing strategies to diverse benzofused sultams.
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Diversity distribution of sultams 2–12, 14a–c and 17a–d, (red spheres) relative to analogous
MLPCN compounds (blue) within a chemical space defined by BCUT polarizability metrics
(x-axis reports values of an AM1 polarizability metric scaled by molecular bond-order
profile; y-axis reports an AM1 polarizability metric scaled by an inverse topological
distance profile).
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Reaction pairing utilizing Sulfonylation–SNAr with amino alcohols.
[a] Sulfonylation: NaHCO3, CH2Cl2, H2O, rt. SNAr: Cs2CO3, DMF, 140 °C, mW.
Mitsunobu: PPh3, DIAD, THF, rt.
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Reaction pairing strategy to access skeletally diverse sultams with an array of amino
alcohols
[a] Sulfonylation: R1NH2 [Compounds 6 & 8, (R1 = Propargyl) 10 and 12 (R1 = nBu)],
NaHCO3, CH2Cl2, H2O, rt. SNAr: Cs2CO3, DMF, 140 °C, mW. Mitsunobu: PPh3, DIAD,
THF, rt.
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Mitsunobu–Intramolecular SNAr strategy to benzofused sultams.
[a] i. Sulfonylation: NaHCO3, CH2Cl2, H2O ii. Mitsunobu: PPh3, DIAD, THF, rt. iii.
Deprotection-SNAr cyclization: TBAF, THF, 150 °C, mW.
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Mitsunobu–azido SNAr–[3+2] cyclization RP strategy to thiadiazepine 6,6-dioxides.
[a] i. Mitsunobu: PPh3, DIAD, THF, rt. ii Azido-SNAr [3+2] Cyclization: NaN3, 18-c-6,
DMF, 90 °C, 6–10 h
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